These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21864797)

  • 1. The application of photosensitisers to tropical pathogens in the blood supply.
    Wainwright M; Baptista MS
    Photodiagnosis Photodyn Ther; 2011 Sep; 8(3):240-8. PubMed ID: 21864797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.
    Blajchman MA
    Transfus Clin Biol; 2009 May; 16(2):70-4. PubMed ID: 19427252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes.
    Corash L
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):549-63. PubMed ID: 11102276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of viruses, bacteria, protozoa and leukocytes in platelet and red cell concentrates.
    Corash L
    Vox Sang; 2000; 78 Suppl 2():205-10. PubMed ID: 10938954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing emerging infectious threats to blood safety for the blood disorders community.
    Trimble SR; Parker CS; Grant AM; Soucie JM; Reyes N
    Am J Prev Med; 2010 Apr; 38(4 Suppl):S468-74. PubMed ID: 20331945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogen-reduction systems for blood components: the current position and future trends.
    Seghatchian J; de Sousa G
    Transfus Apher Sci; 2006 Dec; 35(3):189-96. PubMed ID: 17110168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenothiazinium derivatives for pathogen inactivation in blood products.
    Wainwright M; Mohr H; Walker WH
    J Photochem Photobiol B; 2007 Jan; 86(1):45-58. PubMed ID: 16979899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogen inactivation technology: cleansing the blood supply.
    Klein HG
    J Intern Med; 2005 Mar; 257(3):224-37. PubMed ID: 15715679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.
    Allain JP; Bianco C; Blajchman MA; Brecher ME; Busch M; Leiby D; Lin L; Stramer S
    Transfus Med Rev; 2005 Apr; 19(2):110-26. PubMed ID: 15852240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging infectious threats to the blood supply.
    Dodd RY; Leiby DA
    Annu Rev Med; 2004; 55():191-207. PubMed ID: 14746517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches to minimize infection risk in blood banking and transfusion practice.
    Lindholm PF; Annen K; Ramsey G
    Infect Disord Drug Targets; 2011 Feb; 11(1):45-56. PubMed ID: 21303341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-Borne Pathogens: A Canadian Blood Services Centre for Innovation Symposium.
    Walsh GM; Shih AW; Solh Z; Golder M; Schubert P; Fearon M; Sheffield WP
    Transfus Med Rev; 2016 Apr; 30(2):53-68. PubMed ID: 26962008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus inactivation in blood components by photoactive phenothiazine dyes.
    Wagner SJ
    Transfus Med Rev; 2002 Jan; 16(1):61-6. PubMed ID: 11788930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodecontamination of blood components: advantages and drawbacks.
    Santus R; Grellier P; Schrével J; Mazière JC; Stoltz JF
    Clin Hemorheol Microcirc; 1998 Jul; 18(4):299-308. PubMed ID: 9741671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-transmitted infections.
    Bihl F; Castelli D; Marincola F; Dodd RY; Brander C
    J Transl Med; 2007 Jun; 5():25. PubMed ID: 17553144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging, re-emerging and submerging infectious threats to the blood supply.
    Alter HJ
    Vox Sang; 2004 Jul; 87 Suppl 2():56-61. PubMed ID: 15209880
    [No Abstract]   [Full Text] [Related]  

  • 17. Inactivation of viruses, bacteria, protozoa and leukocytes in platelet and red cell concentrates.
    Corash L
    Dev Biol (Basel); 2000; 102():115-23. PubMed ID: 10794098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress toward a pathogen-free blood supply.
    McCullough J
    Clin Infect Dis; 2003 Jul; 37(1):88-95. PubMed ID: 12830413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogen inactivation: a new paradigm for preventing transfusion-transmitted infections.
    McCullough J
    Am J Clin Pathol; 2007 Dec; 128(6):945-55. PubMed ID: 18024320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of yellow fever virus in plasma after treatment with methylene blue and visible light and in platelet concentrates following treatment with ultraviolet C light.
    Faddy HM; Fryk JJ; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC
    Transfusion; 2019 Jul; 59(7):2223-2227. PubMed ID: 31050821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.